Our findings here reported about the SREBP-2-mediated activation of SND1 transcription in response to sterol-lowering treatments are consistent with a recent study in rat hepatoma cells overexpressing SND1 that evidence a constitutive overactivation of the SREBP-2 regulatory system [34]. The gene discussed is SREBF2; the disease is hepatocellular carcinoma.